ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

34.42 -0.54 (-1.53%)

Streaming Delayed Price Updated: 3:13 PM EST, Feb 3, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	814,450
Open	34.64
Bid (Size)	34.41 (300)
Ask (Size)	34.44 (300)
Prev. Close	34.96
Today's Range	34.26 - 35.12
52wk Range	25.16 - 36.45
Shares Outstanding	166,121,384
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1

January 06, 2026

From Alkermes plc

Via Business Wire

Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025

From Alkermes plc

Via Business Wire

Performance

YTD	+21.8%	+21.8%
1 Month	+22.9%	+22.9%
3 Month	+14.1%	+14.1%
6 Month	+29.2%	+29.2%
1 Year	+11.9%	+11.9%

More News

Alkermes to Participate in Two Upcoming Investor Conferences

November 25, 2025

From Alkermes plc

Via Business Wire

Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge ↗

November 19, 2025

Via Stocktwits

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Preview: Alkermes's Earnings ↗

October 27, 2025

Via Benzinga

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal ↗

November 14, 2025

Via Benzinga

Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid ↗

November 14, 2025

Via Investor's Business Daily

Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes ↗

November 14, 2025

Via Stocktwits

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 13, 2025

Via Benzinga

Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study ↗

November 12, 2025

Via Benzinga

This Alkermes Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗

November 11, 2025

Via Benzinga

ALKERMES PLC (NASDAQ:ALKS) Q3 2025 Earnings Beat Estimates and Drive Stock Surge ↗

October 28, 2025

Via Chartmill

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups ↗

October 24, 2025

Via Benzinga

Breaking Down Alkermes: 8 Analysts Share Their Views ↗

October 23, 2025

Via Benzinga

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz ↗

October 22, 2025

Via Benzinga

Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition

October 22, 2025

Via MarketMinute

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated

October 22, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives. ↗

October 22, 2025

Via Investor's Business Daily

Avadel Stock Rises After Acquisition Offer By Alkermes ↗

October 22, 2025

Via Stocktwits

9 Analysts Assess Alkermes: What You Need To Know ↗

September 26, 2025

Via Benzinga

This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗

September 26, 2025

Via Benzinga

Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings) ↗

September 03, 2025

Via Benzinga

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday ↗

September 03, 2025

Via Benzinga

This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

September 03, 2025

Via Benzinga

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?

Yes, Alkermes plc - Ordinary Shares is publicly traded.

What exchange does Alkermes plc - Ordinary Shares trade on?

Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Alkermes plc - Ordinary Shares?

The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market

What is the current price of Alkermes plc - Ordinary Shares?

The current price of Alkermes plc - Ordinary Shares is 34.42

When was Alkermes plc - Ordinary Shares last traded?

The last trade of Alkermes plc - Ordinary Shares was at 02/03/26 03:13 PM ET

What is the market capitalization of Alkermes plc - Ordinary Shares?

The market capitalization of Alkermes plc - Ordinary Shares is 5.72B

How many shares of Alkermes plc - Ordinary Shares are outstanding?

Alkermes plc - Ordinary Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.